Associations of inflammatory biomarkers with clinical outcomes in degenerative lumbar spinal stenosis: A systematic review
Brain and Spine · 2026 · 6 · 106056
DOI: 10.1016/j.bas.2026.106056 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Brain and Spine, 2026. Verfasst von Michita Noma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, Netherlands. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Inflammatory pathways have been implicated in degenerative lumbar spinal stenosis (LSS), but the clinical relevance of inflammatory biomarkers is unclear. Research question: What associations exist between inflammatory biomarkers and patient-centered outcomes in degenerative LSS, and secondarily with imaging features? Material and methods: We conducted a PRISMA 2020-compliant systematic review. MEDLINE/PubMed, Embase, Cochrane Library, Scopus, Web of Science, CINAHL, and Academic Search Premier were searched from inception to July 4, 2025. We included original adult human studies of degenerative LSS reporting inflammatory biomarkers (tissue, serum/plasma, or cerebrospinal fluid [CSF]) with clinical and/or imaging outcomes. Risk of bias was assessed using a modified Newcastle-Ottawa Scale.
Results
Of 1157 records identified (645 from databases; 512 from citation tracking), 14 studies met inclusion criteria. Biomarker-clinical outcome evidence was sparse and based on single studies: higher CSF NOx was associated with a lower postoperative recovery rate; higher serum MCP-1 with greater short-term satisfaction after epidural steroid injection; and higher serum miR-486-5p with more pain/disability and worse postoperative JOA scores. Most studies linked biomarkers to imaging severity, particularly ligamentum flavum hypertrophy and reduced dural sac cross-sectional area. Only one small study assessed both clinical and imaging outcomes: higher CSF IL-6 associated with smaller dural sac area but not pain intensity or walking distance. Discussion and conclusion: Evidence connecting inflammatory biomarkers to patient-centered outcomes in degenerative LSS is limited. Reported associations are hypothesis-generating and require confirmation in standardized, adequately powered prospective studies before clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Leiden University Medical Center, Albinusdreef 2, Leiden, 2333 ZA, Netherlands.
- Department of Orthopedic Surgery, The University of Tokyo Hospital, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
- Department of Orthopedic Surgery, Tokyo Metropolitan Hiroo General Hospital, 2-34-10, Ebisu, Shibuya-ku, Tokyo, 150-0013, Japan.
- Department of Neurosurgery, Erasmus University Medical Center, Dr. Molewaterplein 40, Rotterdam, 3015 GD, Netherlands.
- Department of Neurosurgery, Spaarne Gasthuis, Boerhaavelaan 22, Haarlem, 2035 RC, Netherlands.
Zitieren
APA
Noma, M., Djuric, N., & Vleggeert-Lankamp, C. (2026). Associations of inflammatory biomarkers with clinical outcomes in degenerative lumbar spinal stenosis: A systematic review. Brain and Spine, 6, 106056. https://doi.org/10.1016/j.bas.2026.106056
Vancouver
Noma M, Djuric N, Vleggeert-Lankamp C. Associations of inflammatory biomarkers with clinical outcomes in degenerative lumbar spinal stenosis: A systematic review. Brain and Spine. 2026;6:106056. doi:10.1016/j.bas.2026.106056
BibTeX
@article{Noma2026,
author = {Noma, Michita and Djuric, Niek and Vleggeert-Lankamp, Carmen},
title = {Associations of inflammatory biomarkers with clinical outcomes in degenerative lumbar spinal stenosis: A systematic review},
journal = {Brain and Spine},
year = {2026},
volume = {6},
pages = {106056},
doi = {10.1016/j.bas.2026.106056}
}
EUVIMED